Distinguishing ASH Clinical Practice Guidelines from Other Forms of ASH Clinical Advice
Copyright © 2024 American Society of Hematology..
The American Society of Hematology (ASH) develops a variety of resources that provide guidance to clinicians on the diagnosis and management of blood diseases. These resources include clinical practice guidelines (CPGs) and other forms of clinical advice. While both ASH CPGs and other forms of clinical advice provide recommendations, they differ with respect to the methods underpinning their development, the principal type of recommendations they offer, their transparency and concordance with published evidence, and the time and resources required for their development. It is crucial that end users be aware of the differences between CPGs and other forms of clinical advice and that producers and publishers of these resources use clear and unambiguous terminology to facilitate their distinction. The objective of this article is to highlight similarities and differences between ASH CPGs and other forms of ASH clinical advice and to discuss the implications of these differences for end users.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
|---|---|
| Enthalten in: |
Blood advances - (2024) vom: 09. Apr. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Cuker, Adam [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 09.04.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1182/bloodadvances.2023011102 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370827961 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370827961 | ||
| 003 | DE-627 | ||
| 005 | 20240410233214.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240410s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1182/bloodadvances.2023011102 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1371.xml |
| 035 | |a (DE-627)NLM370827961 | ||
| 035 | |a (NLM)38593461 | ||
| 035 | |a (PII)bloodadvances.2023011102 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Cuker, Adam |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Distinguishing ASH Clinical Practice Guidelines from Other Forms of ASH Clinical Advice |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 09.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a Copyright © 2024 American Society of Hematology. | ||
| 520 | |a The American Society of Hematology (ASH) develops a variety of resources that provide guidance to clinicians on the diagnosis and management of blood diseases. These resources include clinical practice guidelines (CPGs) and other forms of clinical advice. While both ASH CPGs and other forms of clinical advice provide recommendations, they differ with respect to the methods underpinning their development, the principal type of recommendations they offer, their transparency and concordance with published evidence, and the time and resources required for their development. It is crucial that end users be aware of the differences between CPGs and other forms of clinical advice and that producers and publishers of these resources use clear and unambiguous terminology to facilitate their distinction. The objective of this article is to highlight similarities and differences between ASH CPGs and other forms of ASH clinical advice and to discuss the implications of these differences for end users | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Kunkle, Robert |e verfasserin |4 aut | |
| 700 | 1 | |a Bercovitz, Rachel Sara |e verfasserin |4 aut | |
| 700 | 1 | |a Byrne, Michael T |e verfasserin |4 aut | |
| 700 | 1 | |a Djulbegovic, Benjamin |e verfasserin |4 aut | |
| 700 | 1 | |a Haberichter, Sandra L |e verfasserin |4 aut | |
| 700 | 1 | |a Holter-Chakrabarty, Jennifer |e verfasserin |4 aut | |
| 700 | 1 | |a Lottenberg, Richard |e verfasserin |4 aut | |
| 700 | 1 | |a Pai, Menaka |e verfasserin |4 aut | |
| 700 | 1 | |a Rezende, Suely Meireles |e verfasserin |4 aut | |
| 700 | 1 | |a Seftel, Matthew D |e verfasserin |4 aut | |
| 700 | 1 | |a Silverstein, Roy L |e verfasserin |4 aut | |
| 700 | 1 | |a Terrell, Deirdra R |e verfasserin |4 aut | |
| 700 | 1 | |a Cheung, Matthew C |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Blood advances |d 2016 |g (2024) vom: 09. Apr. |w (DE-627)NLM268683263 |x 2473-9537 |7 nnns |
| 773 | 1 | 8 | |g year:2024 |g day:09 |g month:04 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1182/bloodadvances.2023011102 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 09 |c 04 | ||